Table 1 of Zhao, Mol Vis 2010; 16:1576-1584. Table 1 of Zhao, Mol Vis 2010; 16:1576-1584.
Table 1. Clinical characteristics of the diabetic patients and non-diabetic controls.
Group |
Age (years) |
Sex (M/F) |
Diabetes duration (years) |
FBG (mmol/l) |
PBG (mmol/l) |
HbA1c (%) |
|---|---|---|---|---|---|---|
| Samples used in dot immunobinding assay | ||||||
| CTL | 59.0±9.4 | 8/7 | - | - | - | - |
| DR | 61.3±7.6 | 7/8 | 8.0±6.8 | 9.1±2.4 | 12.4±3.7 | 10.0±2.4 |
| DNR | 61.1±8.4 | 8/7 | 9.0±4.5 | 7.7±3.4 | 11.8±4.2 | 9.9±2.6 |
| Samples used in 1D gel analysis | ||||||
| CTL | 54.4±12.0 | 3/2 | - | - | - | - |
| DR | 64.5±5.0 | 2/2 | 9.8±9.4 | 8.2±1.5 | 10.4±1.7 | 8.0±2.6 |
| DNR | 68.5±5.0 | 1/2 | 8.5±0.7 | 7.9±1.0 | 10.4±1.0 | 7.0±0.9 |
| Samples used in 2D gel analysis | ||||||
| CTL | 57.3±8.6 | 15/15 | - | - | - | - |
| DR | 59.1±10.6 | 15/15 | 11.0±6.1 | 9.4±2.8 | 14.1±5.5 | 10.0±2.3 |
| DNR | 57.3±11.2 | 15/15 | 5.9±4.6* | 9.7±3.7 | 15.6±6.8 | 9.8±2.8 |